Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition

被引:54
|
作者
Napolitano, M. [1 ]
Megna, M. [2 ]
Fabbrocini, G. [2 ]
Nistico, S. P. [3 ]
Balato, N. [2 ]
Dastoli, S. [3 ]
Patruno, C. [3 ]
机构
[1] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy
[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
关键词
DRUG ERUPTION; DISEASES;
D O I
10.1111/bjd.17779
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:604 / 606
页数:3
相关论文
共 50 条
  • [21] Effect of anti-interleukin 12 treatment on murine lyme borreliosis
    Anguita, J
    Persing, DH
    Rincon, M
    Barthold, SW
    Fikrig, E
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04): : 1028 - 1034
  • [22] Anti-interleukin 5 strategies as a potential treatment for asthma - Commentary
    Walker, WS
    THORAX, 1997, 52 (05) : 486 - 486
  • [23] Anti-interleukin 6 receptor antibody treatment in rheumatic disease
    Nishimoto, N
    Kishimoto, T
    Yoshizaki, K
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 : 21 - 27
  • [24] Anti-interleukin 5 treatment and eosinophilic granulomatosis with polyangiitis: A beginning?
    Kroegel C.
    Costabel U.
    Neumann T.
    Der Pneumologe, 2018, 15 (3): : 189 - 192
  • [25] Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes
    Kau, Andrew L.
    Korenblat, Phillip E.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 14 (06) : 570 - 575
  • [26] Phase II study of a human anti-interleukin (IL)-12/IL-23 monoclonal antibody in the treatment of psoriasis
    Langely, RG
    Lebwohl, M
    Leonardi, C
    Yeilding, N
    Guzzo, C
    Wang, Y
    Dooley, L
    Krueger, GG
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A69 - A69
  • [27] Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
    Ferrito, M.
    Cincinelli, G.
    Manara, M.
    Di Taranto, R.
    Favalli, E. G.
    Caporali, R.
    REUMATISMO, 2023, 75 (02) : 76 - 85
  • [28] Interleukin 17-A inhibition in the treatment of psoriasis
    Yiu, Zenas Z. N.
    Griffiths, Christopher E. M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (01) : 1 - 4
  • [29] Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases
    Topaloglu, Rezan
    Batu, Ezgi Deniz
    Orhan, Diclehan
    Ozen, Seza
    Besbas, Nesrin
    PEDIATRIC NEPHROLOGY, 2016, 31 (04) : 633 - 640
  • [30] Targeting of interleukin-17 in the treatment of psoriasis
    Lonnberg, Ann Sophie
    Zachariae, Claus
    Skov, Lone
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2014, 7 : 251 - 259